Literature DB >> 36147641

Expression of Concern on "A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements".

BioMed Research International.   

Abstract

Entities:  

Year:  2022        PMID: 36147641      PMCID: PMC9489367          DOI: 10.1155/2022/9836248

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.246


× No keyword cloud information.
In the article titled “A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements” [1], Reference [31] referred to a study using Vivomixx®. We have recently been made aware of a concern regarding the described composition of the Vivomixx® product, and the publishers of the study protocol [2] and results [3] have been informed. These articles may be subject to correction.
  3 in total

1.  Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial.

Authors:  Sofie Ingdam Halkjaer; Lisbeth Nilas; Emma Malchau Carlsen; Dina Cortes; Thórhallur Ingi Halldórsson; Sjúrdur Frodi Olsen; Anders Elm Pedersen; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Trials       Date:  2016-10-11       Impact factor: 2.279

2.  Multistrain Probiotic Increases the Gut Microbiota Diversity in Obese Pregnant Women: Results from a Randomized, Double-Blind Placebo-Controlled Study.

Authors:  Sofie Ingdam Halkjær; Victoria Elizabeth de Knegt; Bobby Lo; Lisbeth Nilas; Dina Cortes; Anders Elm Pedersen; Hengameh Chloé Mirsepasi-Lauridsen; Lee O'Brien Andersen; Henrik Vedel Nielsen; Christen Rune Stensvold; Thor Bech Johannesen; Thomas Kallemose; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Curr Dev Nutr       Date:  2020-05-27

Review 3.  A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements.

Authors:  Bhagavathi Sundaram Sivamaruthi; Periyanaina Kesika; Natarajan Suganthy; Chaiyavat Chaiyasut
Journal:  Biomed Res Int       Date:  2019-05-09       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.